scispace - formally typeset
D

David B. Schnur

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  17
Citations -  850

David B. Schnur is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Schizophrenia & Orienting response. The author has an hindex of 10, co-authored 17 publications receiving 817 citations.

Papers
More filters
Journal ArticleDOI

Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses

TL;DR: The findings indicate that BPS patients may have distinct anatomical alterations in brain structures involved in the regulation of mood and cognition, as well as alterations in these structures' connection to related brain areas.
Journal ArticleDOI

Dorsal Striatal Size, Shape, and Metabolic Rate in Never-Medicated and Previously Medicated Schizophrenics Performing a Verbal Learning Task

TL;DR: In this paper, the size and metabolic rate of the caudate and putamen in 18 patients with schizophrenia or schizo-affective disorder (n=16) and 24 age-and sex-matched control subjects were found to be significantly smaller in never-medicated patients than in controls.
Journal ArticleDOI

Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients

TL;DR: Attentional modulation of the startle reflex was studied in unmedicated schizophrenia patients and 15 control individuals and demonstrates the importance of the functional integrity of prefrontal cortex to PPI modulation.
Journal ArticleDOI

Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression

TL;DR: The evidence in this study suggests that young adult manic and depressed patients are predominantly similar in cortical rCBF parameters.
Journal ArticleDOI

Hillside study of risk and early detection in schizophrenia.

TL;DR: Individuals with adolescent onset of schizophrenia are considered to be representative of schizophrenia in general and neurocognitive deficits and clinical symptoms are concluded to be two independent classess of risk indicators.